Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 2/20 | 0.56 |
| ▸ | RXRA | P19793 | 1/20 | 0.54 |
| ▸ | RXRB | P28702 | 1/20 | 0.54 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.54 |
| ▸ | ERN1 | O75460 | 1/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.50 |
| ▸ | TTR | P02766 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.49 |
| ▸ | DDT | P30046 | 1/20 | 0.49 |
| ▸ | HNF4A | P41235 | 1/20 | 0.49 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28256321 | 0.88 | KMO (0.55) | KMORXRARXRBERN1FOLH1 | |
| SCHEMBL442496 | 0.87 | KMO (0.63) | KMORXRARXRBERN1FOLH1 | |
| Benzoic Acid SCHEMBL9033308 | 0.87 | HNF4A (0.59) | KMORXRARXRBHSD17B14TTR | |
| Hydrochloric Acid SCHEMBL27574419 | 0.86 | KMO (0.61) | KMORXRARXRBERN1FOLH1 | |
| SCHEMBL17202802 | 0.85 | KMO (0.51) | KMORXRARXRBERN1FOLH1 | |
| SCHEMBL4368940 | 0.84 | FOLH1 (0.60) | KMORXRARXRBHSD17B14ERN1 | |
| SCHEMBL28150203 | 0.84 | ERN1 (0.53) | HSD17B14ERN1 | |
| Terephthalic Acid SCHEMBL9014429 | 0.84 | HNF4A (0.59) | KMORXRARXRBTTRHNF4A | |
| SCHEMBL29629597 | 0.83 | KMO (0.53) | KMORXRARXRBERN1FOLH1 | |
| SCHEMBL407806 | 0.83 | KMO (0.53) | KMORXRARXRBERN1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4139275-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | Syneurx International (Taiwan) Corp. (TW) | 2023-03-01 | — | — | EP | disclosed |
| WO-2021213500-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (CN) | 2021-10-28 | — | — | WO | disclosed |
| US-8372822-B2 | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | PLIVA HRVATSKA D.O.O. (HR) | 2013-02-12 | — | — | US | disclosed |
| US-20120238612-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | PLIVA HRVATSKA D.O.O. (HR) | 2012-09-20 | — | — | US | disclosed |
| US-8217021-B2 | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | PLIVA HRVATSKA D.O.O. (HR) | 2012-07-10 | — | — | US | disclosed |
| EP-2414336-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | Pliva Hrvatska D.O.O. (HR) | 2012-02-08 | — | — | EP | disclosed |
| US-20120022124-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | PLIVA HRVATSKA D.O.O. (HR) | 2012-01-26 | — | — | US | disclosed |
| US-8022093-B2 | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | PLIVA HRVATSKA D.O.O. (HR) | 2011-09-20 | — | — | US | disclosed |
| US-20110196008-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | PLIVA HRVATSKA D.O.O. (HR) | 2011-08-11 | — | — | US | disclosed |
| US-7956048-B2 | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | PLIVA HRVATSKA D.O.O. (HR) | 2011-06-07 | — | — | US | disclosed |
| WO-2010114943-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | PLIVA HRVATSKA D.O.O. (HR) | 2010-10-07 | — | — | WO | disclosed |
| US-20100256212-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | PLIVA HRVATSKA D.O.O. (HR) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022124-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | THPO, MPL, PTGER1 | KMO 3233/4885RXRA 2354/4885RXRB 2882/4885 |
| US-20100256212-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | THPO, MPL, PTGER1 | KMO 3233/4885RXRA 2354/4885RXRB 2882/4885 |
| US-20120238612-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | THPO, MPL, PTGER1 | KMO 3233/4885RXRA 2354/4885RXRB 2882/4885 |
| US-20110196008-A1 | POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF | THPO, MPL, PTGER1 | KMO 3233/4885RXRA 2354/4885RXRB 2882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.